Tobacco Pilot Study for Low Income Smokers

• ClinicalTrials.gov Identifier: NCT03017092
• Recruitment Status: Completed
• First Posted: January 11, 2017
• Last Update Posted: December 26, 2019
• Sponsor: University of Wisconsin, Madison
• Collaborator: National Cancer Institute (NCI)
• Information provided by (Responsible Party): University of Wisconsin, Madison

Tracking Information

• First Submitted Date: January 3, 2017
• First Posted Date: January 11, 2017
• Last Update Posted Date: December 26, 2019
• Actual Study Start Date: January 18, 2017
• Actual Primary Completion Date: January 27, 2017 (Final data collection date for primary outcome measure)

Current Primary Outcome Measures (submitted: January 9, 2017)

Ease of use of tablet-guided tobacco intervention assessed by interview and summarized across study participants [ Time Frame: Immediately after exposure to intervention ]

At the end of the intervention, each study participant will be interviewed regarding how easy the tablet computer was to use. This qualitative information will by summarized across all study participants.

• Original Primary Outcome Measures: Same as current
• Current Secondary Outcome Measures: Not Provided
• Original Secondary Outcome Measures: Not Provided
• Current Other Pre-specified Outcome Measures: Not Provided
• Original Other Pre-specified Outcome Measures: Not Provided

Descriptive Information

• Brief Title: Tobacco Pilot Study for Low Income Smokers
• Official Title: Tobacco Pilot Study for Low Income Smokers
• Brief Summary: Pilot study to test feasibility of delivering a motivational smoking cessation intervention to low income smokers via a computer tablet.
• Detailed Description: Twenty Salvation Army clients will be recruited to pilot test a motivational smoking cessation counseling intervention that is delivered via a tablet computer. Study participants will be given brief instructions on how to use the tablet. They will then complete a brief survey on the tablet. This will be followed by the researcher using the tablet to provide the motivational intervention. Finally, study participants will be interviewed to establish this perceptions of the intervention.
• Study Type: Interventional
• Study Phase: Not Applicable
• Study Design: Allocation: N/A; Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Other
• Condition: Tobacco Use Disorder

Intervention

Behavioral: Tablet-guided tobacco intervention

This intervention, as guided by a tablet computer, is a brief (20 minute) counseling intervention designed to increase motivation to quit smoking and to increase knowledge of methods of quitting.

Study Arms

Experimental: tablet-guided

Study participants will be administered a brief tobacco intervention by a Salvation Army staff person who is guided by a tablet computer

Intervention: Behavioral: Tablet-guided tobacco intervention

• Publications *: Not Provided

Recruitment Information

• Recruitment Status: Completed
• Actual Enrollment (submitted: January 9, 2017): 20
• Original Estimated Enrollment: Same as current
• Actual Study Completion Date: January 27, 2017
• Actual Primary Completion Date: January 27, 2017 (Final data collection date for primary outcome measure)

Eligibility Criteria

Inclusion Criteria:

• current smoker (≥ 10 cigarettes/week for the past six months who are not currently trying to quit)
• age ≥ 18 years
• English speaking/writing

Exclusion Criteria:

• not receiving services for the Salvation Army

Sex/Gender

• Sexes Eligible for Study: All

• Ages: 18 Years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Contacts: Contact information is only displayed when the study is recruiting subjects
• Listed Location Countries: United States

Administrative Information

• NCT Number: NCT03017092
• Other Study ID Numbers: 2016-1442; 1R35CA197573-01 ( U.S. NIH Grant/Contract ); A534252 ( Other Identifier: UW Madison ); SMPH\MEDICINE\TOBACCO RE ( Other Identifier: UW Madison )
• Has Data Monitoring Committee: No

U.S. FDA-regulated Product

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

• IPD Sharing Statement: Not Provided
• Responsible Party: University of Wisconsin, Madison
• Study Sponsor: University of Wisconsin, Madison
• Collaborators: National Cancer Institute (NCI)
• Investigators: Not Provided
• PRS Account: University of Wisconsin, Madison
• Verification Date: May 2017